Heron Therapeutics
HRTX
#8256
Rank
โ‚น21.59 B
Marketcap
โ‚น117.76
Share price
0.00%
Change (1 day)
-14.14%
Change (1 year)

Revenue for Heron Therapeutics (HRTX)

Revenue in 2025 (TTM): โ‚น13.40 Billion

According to Heron Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น13.94 Billion. In 2024 the company made a revenue of โ‚น12.37 Billion an increase over the revenue in the year 2023 that were of โ‚น10.57 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Heron Therapeutics from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น13.40 B8.31%
2024 โ‚น12.37 B17.03%
2023 โ‚น10.57 B18.7%
2022 โ‚น8.90 B38.64%
2021 โ‚น6.42 B-0.86%
2020 โ‚น6.48 B-37.72%
2019 โ‚น10.40 B92.15%
2018 โ‚น5.41 B175.75%
2017 โ‚น1.96 B2160.27%
2016 โ‚น86.91 M
2015 N/A
2014 N/A
2013 N/A
2012 N/A-100%
2011 โ‚น34.17 M-41.38%
2010 โ‚น58.29 M-0.36%
2009 โ‚น58.51 M229%
2008 โ‚น17.78 M
2005 โ‚น0.24 B3.66%
2004 โ‚น0.23 B6.01%
2003 โ‚น0.22 B-16.75%
2002 โ‚น0.26 B25.27%
2001 โ‚น0.21 B34.76%
2000 โ‚น0.15 B-82.92%
1999 โ‚น0.91 B9.27%
1998 โ‚น0.84 B17.7%
1997 โ‚น0.71 B5.83%
1996 โ‚น0.67 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Alkermes
ALKS
โ‚น136.76 B 880.89%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Pacira Biosciences
PCRX
โ‚น64.43 B 362.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚น5.62 B-59.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น22.58 B 61.98%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
โ‚น10.85 B-22.11%๐Ÿ‡บ๐Ÿ‡ธ USA